Skip to main content
Health Futures Institute

Case Studies

We are using some of the most advanced technology in the world to study humans in the total environment – genes, lifestyle and environmental factors – to improve health and prevent disease.

 

Delivering a novel test for COVID19

Researchers at the Centre for Molecular Medicine and Innovative Therapeutics are developing a novel paper-based COVID19 testing method to deliver accurate results in minutes.

Find out more
 

Tele-rehab for people living with multiple sclerosis

Students and researchers from Murdoch’s Centre for Molecular Medicine and Innovative Therapeutics are investigating ways to increase the number of Australians with multiple sclerosis (MS) participating in exercise programs and improve the telehealth services and programs delivered to the MS community.

Find out more
 

Identifying patients at risk of rapid progression in Parkinson's disease

Researchers from Murdoch’s Centre for Molecular Medicine and Innovative Therapeutics are exploring the genetics and molecular pathology of Parkinson’s disease with the goal of improving the precision and clinical management of patients.

Find out more
 

Identifying the cause of multiple sclerosis

Murdoch researchers are delving into the clinical, laboratory, radiological, and genetic aspects of multiple sclerosis (MS) to increase our understanding of what causes the disease. These findings are fundamental in developing better diagnostic strategies and effective treatments.

Find out more
 

Pioneering treatments for Duchenne muscular dystrophy

Research led by Professor Steve Wilton and Professor Sue Fletcher and licensed to Sarepta Therapeutics has delivered two treatments for Duchenne muscular dystrophy (DMD), with the drugs gaining accelerated approval by the U.S. Food and Drug Administration.

Find out more
 

Exploring how exercise can improve cognitive function

Research from Murdoch’s Centre for Healthy Ageing sought to investigate the effect of moderate-intensity and high-intensity exercise on cognitive function.

Find out more
 

Identifying personalities predisposed to dementia

Research from Murdoch’s Centre for Healthy Ageing suggests certain personality traits are associated with developing dementia.

Find out more
 

Baby Coming You Ready

Perinatal mental health issues such as depression and anxiety can result in detrimental impacts on pregnancy and postnatal periods. After recognising that current techniques for monitoring Aboriginal women’s social and emotional wellbeing in pregnancy were not culturally sensitive, ‘Baby Coming - You Ready?’ was developed. This innovative technology based screening tool has been designed by and with Aboriginal community members to assist young parents during pregnancy and their child's first year.

Find out more
 

Birthing on Noongar Boodjar

Australian maternity care systems have not adequately considered the foundations required to nourish healthy futures for Aboriginal families. These systems have not been designed to provide the best start in life for Aboriginal children, which has resulted in well documented unequal life course health outcomes experienced by Aboriginal people.

Find out more
 

Managing glucose and weight through exercise

Exercise is a cornerstone for the prevention and management of Type 2 Diabetes. However, until now, when to exercise to derive the greatest benefit was unknown. This study found that involvement in a structured exercise program is not only key to improvin blood glucose levels, but that this exercise can be performed at any time of day to have a profound impact on blood glucose levels.

Find out more
 

Unravelling drug hypersensitivity

Professor Elizabeth Phillips is leading the Drug Hypersensitivity Research Group to investigate the genetics and mechanisms behind drug hypersensitivity. Their research is saving lives through the discovery of new ways to prevent or diagnose and treat these life-threatening reactions earlier.

Find out more
 

Powering COVID-19 research through genomics

The Genomics Core Research Facility is playing a large role in progressing COVID-19 research, helping scientists around the world to dive into the complex genetics behind the virus.

Find out more
 

TCR sequencing to track cancer immunity

The Genomics Core Research Facility is enabling researchers to investigate what causes T-cells to drive a negative or positive immune response to cancers. This knowledge is being used to inform the development of tailored vaccines using a neoantigen approach to eradicate cancerous tumours.

Find out more